Results 141 to 150 of about 207,399 (316)

Exercise‐specific plasma proteomic signatures in racehorses: Candidates for training adaptation and peak load monitoring

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Racehorses undergo profound physiological changes with training and competition, but current biomarkers inadequately capture the complex molecular dynamics of exercise. This study aimed to identify novel plasma biomarkers of training adaptation and peak load using high‐throughput proteomics.
Jowita Grzędzicka   +4 more
wiley   +1 more source

A Clinicopathological Study of 24 Cases of DFSP

open access: yesJournal of Plastic and Reconstructive Surgery
Objectives: Dermatofibrosarcoma protuberans (DFSP) usually arises in the dermis and spreads to the underlying subcutaneous tissue (cutaneous DFSP). However, it rarely appears in the subcutaneous tissue (subcutaneous DFSP).
Miyako Kachi   +7 more
doaj  

Human CD34+/KDR+ Cells Are Generated From Circulating CD34+ Cells After Immobilization on Activated Platelets

open access: yes, 2010
OBJECTIVE: To determine whether CD34(+)/kinase-insert domain-containing receptor (KDR)(+) cells are generated in the peripheral circulation (because in bone marrow and in G-CSF-mobilized peripheral blood,
Tamsma, J.   +13 more
core   +1 more source

Mass culture of equine synovial fluid‐derived mesenchymal stromal cells using nonwoven polyethylene terephthalate fabrics

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Culture protocols need to yield 100 million equine synovial fluid (SF)‐derived mesenchymal stromal cells (SF‐MSCs) in around 3 weeks are needed, before these cells can be evaluated as agents of articular repair in clinical trials. Objectives To investigate mass culture of equine SF‐MSC culture protocols using nonwoven polyethylene ...
Miho Daniel Yoshitomi   +5 more
wiley   +1 more source

Superficial CD34 Positive Fibroblastic Tumor: A rare mesenchymal tumor of borderline malignant potential.

open access: yesJournal of Pathology of Nepal
Superficial CD34 positive fibroblastic tumor is a rare soft tissue tumor first brought to light by Jodi M Carter in 2014. Several cases have been reported since, and they have been newly included in the recent WHO classification under the fibroblastic ...
Pradnya Kamble   +2 more
doaj   +1 more source

Capture of CD34+ exosomes from total exosomal fractions by CD34+ microbeads.

open access: yes, 2014
Isolated Kasumi-1 exosomes (Kas) and total exosome fractions isolated by ultracentrifugation from normal donor plasma (NC) or from CD34+ AML patient plasma (AML) were used for capture with CD34 microbeads.
Chang Sook Hong (610216)   +3 more
core   +1 more source

Human CD34+ cell preparations contain over 100-fold greater NOD/SCID mouse engrafting capacity than do CD34− cell preparations

open access: yes, 2001
Objective. The CD34 cell surface marker is used widely for stem/progenitor cell isolation. Since several recent studies reported that CD34- cells also have in vivo engrafting capacity, we quantitatively compared the engraftment potential of CD34+ vs CD34-
Wing Leung   +15 more
core   +1 more source

Current Progress in Differentiating Crohn's Disease From Intestinal Tuberculosis

open access: yesiLABMED, EarlyView.
Currently, there are various methods from different fields used to differentiate Crohn's disease from intestinal tuberculosis (ITB). Endoscopic findings are an important cornerstone. They can be used individually or in combination (models) to demonstrate excellent discriminative ability.
Chuyao Zhang, Xiaoyin Zhang
wiley   +1 more source

CD34

open access: yes, 2021
Joachim Feger, Daniel Bell
openaire   +1 more source

Unveiling the roles of extracellular vesicles in hematologic malignancies: Pathogenesis, diagnostic tools, and clinical translation

open access: yesInterdisciplinary Medicine, EarlyView.
Extracellular vesicles play pivotal roles in both healthy hematopoiesis and hematologic malignancies. They not only regulate hematopoietic stem cell fitness but also drive cancer progression and drug resistance. Their clinical potential spans from serving as non‐invasive biomarkers to acting as innovative therapeutic platforms and drug delivery ...
Fengyu Chen   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy